BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21883488)

  • 1. The prevalence of dysplasia and malignant lip lesions in transplant patients.
    Nolan A; Girdler NM; Seymour RA; Thomason JM
    J Oral Pathol Med; 2012 Feb; 41(2):113-8. PubMed ID: 21883488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients.
    King GN; Healy CM; Glover MT; Kwan JT; Williams DM; Leigh IM; Worthington HV; Thornhill MH
    N Engl J Med; 1995 Apr; 332(16):1052-7. PubMed ID: 7898522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between skin cancer and HLA antigens in renal-transplant recipients.
    Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
    N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
    Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
    Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
    Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
    Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA matching: univariate and multivariate analyses of UNOS Registry data.
    Cicciarelli J; Cho Y
    Clin Transpl; 1991; ():325-33. PubMed ID: 1820128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 9. No association between infections, HLA type and other transplant-related factors and risk of cutaneous squamous cell carcinoma in solid organ transplant recipients.
    Ingvar Å; Ekström Smedby K; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Acta Derm Venereol; 2012 Nov; 92(6):609-14. PubMed ID: 22293782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solar cheilosis: an ominous precursor: part I. Diagnostic insights.
    Jadotte YT; Schwartz RA
    J Am Acad Dermatol; 2012 Feb; 66(2):173-84; quiz 185-6. PubMed ID: 22243721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet radiation.
    Gallagher RP; Lee TK; Bajdik CD; Borugian M
    Chronic Dis Can; 2010; 29 Suppl 1():51-68. PubMed ID: 21199599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study.
    Opelz G; Wujciak T
    N Engl J Med; 1994 Mar; 330(12):816-9. PubMed ID: 8068075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression and other risk factors for lip cancer after kidney transplantation.
    van Leeuwen MT; Grulich AE; McDonald SP; McCredie MR; Amin J; Stewart JH; Webster AC; Chapman JR; Vajdic CM
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):561-9. PubMed ID: 19190169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B mismatch: an equally strong prognostic factor for kidney transplantation when compared with HLA-DR mismatch.
    Sautner T; Mittlböck M; Herbst F; Schwartz D; Mühlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):224-5. PubMed ID: 8438279
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of the donor age effect on kidney transplants.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S; Cho YW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):366-72. PubMed ID: 9361925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States).
    Pogoda JM; Preston-Martin S
    Cancer Causes Control; 1996 Jul; 7(4):458-63. PubMed ID: 8813434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M; Le Blanc K; Ringdén O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M
    Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.